Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 674 participants.

Also called NCT06835491

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 674 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06835491
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06835491. Randomized; no masking; primary purpose prevention. Start 2025-11-06 (actual); primary completion 2027-01-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
Acronym
PARACA
Condition
Ventricular Arrhythmias and Cardiac Arrest
Intervention (Drug)
Amiodarone
Lead sponsor
Versailles Hospital (class: other)

Record details

Record id
cardio:ct-nct06835491
Content hash
9078c138b0600252bfae53a9eaddf0c04990f62c753fdadf693a98f52a7d7f42